5,6-dichloro-n-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]nicotinamide 570403-04-2
570403-04-2
Pharmaceutical Grade
99%
Zison
foil bag
2023-02-28
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
5,6-dichloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]nicotinamide
Other Name:5,6-Dichloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)nicotinamide;570403-04-2;5,6-dichloro-n-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]nicotinamide;SCHEMBL1667260;AMY40534;5,6-dichloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]pyridine-3-carboxamide
CAS No.:570403-04-2
Molecular Formula:C23H24Cl3N5OS2
InChIKeys:ZGOWFPLUBDKGAV-UHFFFAOYSA-N
Molecular Weight:557.0
Exact Mass:555.049
Categories:
Characteristics-
PSA:
117.84
XLogP3:7.0097
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Location:
Room 410, Building 9, No. 2566, Century Avenue, Jinan, 250104, China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2021
-
Certifications:
business license,ISO
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
